IntrinsicIntrinsic

Dividends & Buybacks ·

Shuttle Pharmaceuticals Holdings, Inc. implemented a 1-for-10 reverse stock split of its common stock, effective at…

SHPHShuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc. implemented a 1-for-10 reverse stock split of its common stock, effective at the start of trading on June 11, 2026. The split was authorized by stockholders at the 2026 annual meeting and approved by the board of directors on June 1, 2026. The split adjusted the exercise and conversion prices of outstanding warrants, restricted stock units, and convertible preferred stock proportionally. Shuttle Pharmaceuticals Holdings, Inc. is a pharmaceutical company focused on developing and commercializing specialty pharmacy products.

More from Shuttle Pharmaceuticals Holdings, Inc.

Explore SHPH